Press Release

The Global Physician Dispensed Cosmeceuticals Market size was valued at USD 8.3 billion in 2021 and is expected to grow by USD 14.12 billion in 2030 at a CAGR of 7.8% during the forecast period.

                           Request Free Sample To Learn More About This Report

The expanding importance of beauty and appearance, as well as rising anti-aging awareness, will propel the physician dispensed cosmeceuticals market forward. Factors such as growing awareness of the safety and effectiveness of physician dispensed cosmeceuticals, as well as an increase in user preference for a specific solution to various skin problems such as age spot or acne spot reduction, are expected to drive the Physician Dispensed Cosmeceuticals Market forward during the forecast period.  

During the COVID-19 epidemic, the rising e-Commerce industry and widespread adoption of online shopping applications made it easier for people to order things from the comfort of their own homes. These discoveries are causing the market for physician-dispensed cosmeceuticals to grow. However, businesses must address negative market attitudes, as cosmeceuticals demand is growing slowly due to delayed product movement. Nonetheless, brands and manufacturers are rethinking their supply chains in order to avoid product delivery delays.

                           Request Free Sample To Learn More About This Report

The need for cosmeceuticals to eliminate outward ageing indications is driven by a rise in personal maintenance awareness among the old age population and changing views among the middle aged and ageing population in developing nations. Furthermore, as more middle and upper-class women as well as men in developed nations become aware of cosmeceuticals, the global physician-dispensed cosmeceuticals market grows. In poor places, women's education has increased access to newspapers, journals, and advertisements, which tend to give prominent knowledge to judge real and effective cosmeceuticals.  

Dermatologists and skincare professionals are starting their own businesses with low-cost, locally manufactured goods developed in their own clinics. As a result of this tendency, new firms have entered Asia Pacific's developing markets. Dermatologists that have lately entered the global physician dispensed cosmeceuticals business, such as ZO Skin Health, Inc., operate a variety of cosmetic professional enterprises specializing in manufacturing and marketing cosmeceuticals.   

                           Request Free Sample To Learn More About This Report

Asia Pacific physician-dispensed cosmeceutical market is expected to increase significantly. The desire to maintain a young appearance and beauty for a long time is driving demand for effective physician-dispensed cosmeceuticals in the region. Moreover, the Asia Pacific market will be driven by key market players' increasing focus on expansion in Asia Pacific countries, the region's large customer base, and increased awareness of physician-dispensed cosmeceuticals. Due to the increased choice of individuals to adopt various techniques to maintain long-lasting beauty and young appearance, Asia Pacific holds the greatest share of the global physician dispensed cosmeceuticals market. Furthermore, the presence of a robust consumer base is another important factor supporting regional market growth. 

KEY INDUSTRY DEVELOPMENTS:  

In April 2021, Neutrogena's 'People with Skin' campaign is part of the company's long-term commitment to enhancing skin health for everyone. Through this program, the company is committed to improving skin health in the United States through advocacy, knowledge, education, and openness.

In April 2019, Merz Pharma, a global leader in medical aesthetics, announced the launch of Belotero Revive dermal filler containing a unique combination of HA and glycerol that is intended to improve skin hydration, elasticity, and firmness while also addressing the appearance of fine lines and wrinkles.

Read More Details On This Report: https://extrapolate.com/Retail/physician-dispensed-cosmeceuticals-market/25768